Related Experiment Video
Updated: Aug 23, 2025

Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways
Published on: December 9, 2013
[Sex-related differences in the treatment of coronary artery disease]
Antonino Di Franco1, Giorgia Bonalumi2, Mario Gaudino1
1Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA.
Insights
Investigating sex differences in coronary artery disease treatment outcomes is crucial. Current risk scores and treatments may not adequately address women
Area of Science:
- Cardiology and cardiovascular disease research.
- Sex-based differences in medical treatment outcomes.
- Clinical decision-making in cardiovascular interventions.
Background:
- Differential outcomes between men and women in coronary artery disease (CAD) treatment require further investigation.
- Existing cardiovascular risk scores are often based on male populations, potentially limiting their accuracy for women.
- There's a lack of sex-specific recommendations for diagnosing and treating CAD.
Approach:
- Reviewing and synthesizing the latest scientific evidence on CAD treatment outcomes in men and women.
- Analyzing outcomes based on percutaneous coronary intervention (PCI) and surgical revascularization strategies.
- Highlighting the importance of considering sex-based anatomical, functional, and risk factor differences.
Key Points:
- Sex-based differences in anatomical features, functional characteristics, and risk factors influence CAD treatment strategies.
- Current risk stratification tools may not accurately predict cardiovascular risk in women.
- The need for sex-specific diagnostic and therapeutic guidelines in managing CAD is increasingly recognized.
Conclusions:
- Evidence suggests that sex is a significant factor in CAD treatment outcomes.
- Therapeutic strategies for CAD should be individualized, considering sex-specific characteristics.
- Further research is needed to develop and validate sex-specific approaches for CAD management.
Abstract:
Differential outcomes between men and women following the treatment of coronary artery disease are currently under investigation. An increasing amount of evidence supports the concept that the differential anatomical features, functional characteristics, and risk factors between the two sexes should be considered in decision making for the therapeutic strategy to adopt in patients with coronary artery disease. Most risk scores have been developed based on predominantly male populations and might not work well for predicting cardiovascular risk in women. Moreover, there are currently no specific recommendations for a differential diagnostic work-up or treatment based on sex. We review and discuss the latest evidence on the outcomes of men and women undergoing treatment of coronary artery disease by means of percutaneous or surgical revascularization.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease I: Introduction
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Angina IV: Management
Coronary Artery Disease IV: Preventive Measures
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

